Editor's picks

Editor's picks: impactful articles in interventional cardiology

Stay up to date with new literature, studies and trials published in major journals

Struggling to keep up with the mass of scientific information in interventional cardiology? On this page you will find a selection of recent articles published in major journals in the field - use it to guide your reading!

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial

February 2018, Journal of the American College of Cardiology, Ioanna Kosmidou et al.

This study sought to determine the incidence of new-onset atrial fibrillation following percutaneous coronary intervention and coronary artery bypass grafting for left main coronary artery disease and its effect on 3-year cardiovascular outcomes.

view full article

Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes

7 February 2018, JAMA Cardiology, Mauro Chiarito et al.

A systematic review and meta-analysis to evaluate the safety and efficacy of direct oral anticoagulants in addition to antiplatelet therapy after acute coronary syndromes, focusing on treatment effects stratified by baseline clinical presentation (non–ST-segment elevation ACS vs ST-segment elevation myocardial infarction).

view full article

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease

February 2018, Journal of the American College of Cardiology, Sameer Bansilal et al.

Patients with prior myocardial infarction (MI) and multivessel coronary disease (MVD) are at high risk for recurrent coronary events. The authors investigated the efficacy and safety of ticagrelor versus placebo in patients with MVD in the PEGASUS-TIMI 54 trial.

view full article

Three-Year Outcomes With the Absorb Bioresorbable Scaffold

30 January 2018, Circulation, Ziad A. Ali et al.

The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3 years after coronary artery implantation. The safety and effectiveness of BVS through this critical 3-year period have not been characterized.

view full article

1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor

4 January 2018, Journal of the American College of Cardiology, Zuzana Motovska et al.

Early outcomes of patients in the PRAGUE-18 (Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction) study did not find any significant differences between 2 potent P2Y12 inhibitors.

view full article